Aviir pumps up with $1M for heart diagnostics

Aviir, the Palo Alto, Calif. company that turned Stanford research into technology used to diagnose heart conditions, has brought in $1 million in equity, debt, rights and securities, according to a filing with the SEC. It adds this amount to $1 million raised in August and $7.8 million in bridge financing secured in January from Aberdare Ventures, Bay City Capital and New Leaf Venture Partners. Before that it raised funds in March 2008 amounting to $1.5 million.

Next Story:
Previous Story:

About the Author,

Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.

blog comments powered by Disqus